Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment

Published:2023-07-04 Issue:4 Volume:43 Page:93-101
ISSN:1079-9893
Container-title:Journal of Receptors and Signal Transduction
language:en
Short-container-title:Journal of Receptors and Signal Transduction

Author:

Liao Yao-Qing¹,Fang Bin-Bo²,Wu Qing-Xia³,Dong Wei-Ying¹,Deng Guan-Ming¹

Affiliation:

1. Zhu Hai Center for Maternal and Child Health Care, Zhu Hai Women and Children’s Hospital, Zhuhai, Xiangzhou, China

2. Department of Medicine, Taizhou University, Zhejiang, China

3. The First People’s Hospital of Shunde, Shunde Hospital of Southern Medical University, Foshan, China

Funder

The Taizhou Municipal Science and Technology Bureau

The Wenling Social Development Science and Technology Project

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10799893.2023.2291562

Reference51 articles.

1. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

2. Molecular Interactions of Arterial Hypertension in Its Target Organs

3. Untreated Hypertension and Subsequent Incidence of Colorectal Cancer: Analysis of a Nationwide Epidemiological Database

4. Association between hypertension and oral cancer prognosis in non-smoking and non-drinking women;Wang H;Wei Sheng Yan Jiu,2021

5. Occurrence of hypertension during third‐line anlotinib is associated with progression‐free survival in patients with squamous cell lung cancer ( SCC ): A post hoc analysis of the ALTER0303 trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3